The Conversation (0)
- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
Top Stocks
Top Resource Stocks
Top Tech Stocks
Top Life Science Stocks
Trending
Trending Articles
Trending Press Releases
Trending Companies
Trending Reports
Resource
Popular Lists
Investing Ideas
Outlook Reports
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
Investing Guides
Tech
Popular Lists
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
Investing Ideas
Outlook Reports
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
Investing Guides
Life Science
Popular Lists
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
Outlook Reports
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
Investing Guides
Xtant Medical Enters into Restructuring and Exchange Agreement with All Holders of Outstanding Convertible Notes
Jan. 19, 2018 08:48AM PST
Medical Device InvestingXtant™ Medical Holdings (NYSE:XTNT), announced that it has entered into a Restructuring and Exchange Agreement with ROS Acquisition Offshore LP, OrbiMed Royalty Opportunities II LP, and all of the other holders of all of Xtant’s outstanding 6.00% convertible senior unsecured notes due 2021 on January 11, 2017. As quoted in the press release: “We are …
Xtant™ Medical Holdings (NYSE:XTNT), announced that it has entered into a Restructuring and Exchange Agreement with ROS Acquisition Offshore LP, OrbiMed Royalty Opportunities II LP, and all of the other holders of all of Xtant’s outstanding 6.00% convertible senior unsecured notes due 2021 on January 11, 2017.
As quoted in the press release:
“We are pleased to have signed an agreement to restructure and recapitalize our debt with the noteholders. This will reposition the company for long-term growth and allow the company to regain compliance with the NYSE American.” said Carl O’Connell, Chief Executive Officer of Xtant Medical, “Furthermore, the private placement will provide the liquidity to meet our operating needs going forward.”
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.